Bleeding risks in kidney patients on blood thinners
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study looks at how often bleeding happens in people with chronic kidney disease who are taking blood thinners (anticoagulants) for conditions like blood clots, mechanical heart valves, or atrial fibrillation (an irregular heartbeat). It aims to identify risk factors for bleeding to help doctors manage treatment more safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease (CKD), whether or not you are on dialysis.
- You are currently taking a blood thinner (anticoagulant) for a reason like a blood clot in your leg or lung, a mechanical heart valve, or to prevent stroke from atrial fibrillation with risk factors.
- You have not had a major bleeding problem or a family history of bleeding disorders.
- You do not have serious liver disease that affects blood clotting.
- You are not pregnant or breastfeeding, and you are able to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of blood thinners (vitamin K antagonists and factor Xa inhibitors) versus no blood thinner in people with atrial fibrillation who are on dialysis or have very advanced kidney disease. It aims to see which option is safest and most effective for preventing strokes and bleeds.
This study compares two ways to manage atrial fibrillation (an irregular heartbeat) in people on dialysis. One approach uses a blood thinner called apixaban, and the other does not use blood thinners. The goal is to see which approach better prevents strokes and bleeding.
This trial tests whether a blood test looking at platelets and tiny cell particles can help predict future blood clots or bleeding in people who have both chronic kidney disease and a recent heart attack. The goal is to improve treatment safety.
This study tests whether giving community pharmacists access to your kidney function can help reduce bleeding when you take direct oral anticoagulants (blood thinners). You may join if you have a prescription for these medications and visit a partner pharmacy.
This trial tests whether the blood thinner rivaroxaban can prevent dangerous blood clots in people with a kidney condition called membranous nephropathy who have low albumin levels and are at high risk for clots.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
Hear when a new Chronic Kidney Diseases Receiving Anticoagulants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.